Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cinnoxicam
2. Sinartrol
3. Spa-s 510
1. Cinnoxicam
2. 87234-24-0
3. Spa-s-510
4. Piroxicam Cinnamate [usan]
5. Piroxicam Cinnamic Acid Ester
6. Spa-s-51o
7. 7e8q32n75n
8. Piroxicam Cinnamate (usan)
9. [2-methyl-1,1-dioxo-3-(pyridin-2-ylcarbamoyl)-1lambda6,2-benzothiazin-4-yl] (e)-3-phenylprop-2-enoate
10. Sinartrol
11. Unii-7e8q32n75n
12. Schembl43470
13. Chembl2106889
14. Dtxsid10236212
15. Chebi:135749
16. Zinc608032
17. Piroxicam Cinnamate [who-dd]
18. Akos015896439
19. 4-hydroxy-2-methyl-n-2-pyridyl-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide, Cinnamate (ester)
20. Piroxicam Cinnamic Acid Ester [mi]
21. Hy-106583
22. Cs-0026104
23. D05512
24. A842045
25. Q27268143
26. (e)-3-phenyl-2-propenoic Acid [2-methyl-1,1-dioxo-3-[oxo-(2-pyridinylamino)methyl]-1$l^{6},2-benzothiazin-4-yl] Ester
27. [2-methyl-1,1-bis(oxidanylidene)-3-(pyridin-2-ylcarbamoyl)-1$l^{6},2-benzothiazin-4-yl] (e)-3-phenylprop-2-enoate
28. [2-methyl-1,1-dioxo-3-(pyridin-2-ylcarbamoyl)-16,2-benzothiazin-4-yl] (e)-3-phenylprop-2-enoate
29. 2-propenoic Acid, 3-phenyl-, 2-methyl-3-((2-pyridinylamino)carbonyl)-2h-1,2-benzothiazin-4-yl Ester, S,s-dioxide
| Molecular Weight | 461.5 g/mol |
|---|---|
| Molecular Formula | C24H19N3O5S |
| XLogP3 | 4.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 6 |
| Exact Mass | 461.10454189 g/mol |
| Monoisotopic Mass | 461.10454189 g/mol |
| Topological Polar Surface Area | 114 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 902 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
Global Sales Information
ABOUT THIS PAGE
A Piroxicam Cinnamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Piroxicam Cinnamate, including repackagers and relabelers. The FDA regulates Piroxicam Cinnamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Piroxicam Cinnamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Piroxicam Cinnamate supplier is an individual or a company that provides Piroxicam Cinnamate active pharmaceutical ingredient (API) or Piroxicam Cinnamate finished formulations upon request. The Piroxicam Cinnamate suppliers may include Piroxicam Cinnamate API manufacturers, exporters, distributors and traders.
Piroxicam Cinnamate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Piroxicam Cinnamate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Piroxicam Cinnamate GMP manufacturer or Piroxicam Cinnamate GMP API supplier for your needs.
A Piroxicam Cinnamate CoA (Certificate of Analysis) is a formal document that attests to Piroxicam Cinnamate's compliance with Piroxicam Cinnamate specifications and serves as a tool for batch-level quality control.
Piroxicam Cinnamate CoA mostly includes findings from lab analyses of a specific batch. For each Piroxicam Cinnamate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Piroxicam Cinnamate may be tested according to a variety of international standards, such as European Pharmacopoeia (Piroxicam Cinnamate EP), Piroxicam Cinnamate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Piroxicam Cinnamate USP).
LOOKING FOR A SUPPLIER?
